Emergent BioSolutions Inc.
EBS
$5.71
$0.203.63%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -127.26% | 140.55% | -3,245.56% | 118.18% | 81.21% |
| Total Depreciation and Amortization | -1.52% | -7.37% | 2.15% | -5.74% | 5.71% |
| Total Amortization of Deferred Charges | 132.84% | -234.00% | -27.54% | 21.05% | 0.00% |
| Total Other Non-Cash Items | 118.32% | -150.88% | 1,124.72% | -354.29% | -98.44% |
| Change in Net Operating Assets | -230.03% | -68.14% | 311.18% | -327.80% | -34.95% |
| Cash from Operations | -151.98% | 223.58% | 175.88% | -295.02% | -46.50% |
| Capital Expenditure | 70.69% | -26.09% | 57.41% | 5.26% | 9.52% |
| Sale of Property, Plant, and Equipment | -96.05% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -74.46% | 2,534.78% | 57.41% | 5.26% | 39.68% |
| Total Debt Issued | -100.00% | 1,360.00% | -70.00% | 150.00% | -- |
| Total Debt Repaid | 100.00% | -582.64% | -579.78% | 44.03% | 62.94% |
| Issuance of Common Stock | -91.40% | 1,228.57% | -- | -- | -- |
| Repurchase of Common Stock | 0.00% | -50.00% | 50.00% | -300.00% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 179.66% | -- | -- | -- |
| Cash from Financing | 100.28% | -254.22% | -225.06% | 765.96% | 110.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -236.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -159.48% | 1,167.50% | 75.54% | -236.82% | 3,087.50% |
